Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thromboembolism (DVT) and Pulmonary Embolism (PE). A Study of BAY59-7939 in the Prevention of Venous Thrombo Embolism (VTE) in Subjects Undergoing Elective Total Knee Replacement.
Public ClinicalTrials.gov record NCT00362232. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
RECORD 4 Study: REgulation of Coagulation in ORthopedic Surgery to Prevent DVT and PE; a Controlled, Double-blind, Randomized Study of BAY59-7939 in the Prevention of VTE in Subjects Undergoing Elective Total Knee Replacement
Study identification
- NCT ID
- NCT00362232
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Bayer
- Industry
- Enrollment
- 3,148 participants
Conditions and interventions
Conditions
Interventions
- Rivaroxaban (Xarelto, BAY59-7939) Drug
- Enoxaparin Drug
- Placebo: tablet of Rivaroxaban Drug
- Placebo: syringes of Enoxaparin Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2006
- Primary completion
- Dec 31, 2006
- Completion
- Dec 31, 2007
- Last update posted
- Nov 3, 2014
2006 – 2008
United States locations
- U.S. sites
- 40
- U.S. states
- 18
- U.S. cities
- 39
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | 35209 | — |
| Not listed | Tuscaloosa | Alabama | 35406 | — |
| Not listed | Phoenix | Arizona | 85023 | — |
| Not listed | Little Rock | Arkansas | 72205 | — |
| Not listed | Bakersfield | California | 93309 | — |
| Not listed | Encinitas | California | 92024 | — |
| Not listed | Fountain Valley | California | 92708 | — |
| Not listed | La Jolla | California | 92037 | — |
| Not listed | Torrance | California | 90502-2004 | — |
| Not listed | Yuba City | California | 95991 | — |
| Not listed | Centennial | Colorado | 80112 | — |
| Not listed | Denver | Colorado | 80230 | — |
| Not listed | Englewood | Colorado | 80110 | — |
| Not listed | Boynton Beach | Florida | 33472-2952 | — |
| Not listed | Clearwater | Florida | 33756 | — |
| Not listed | DeLand | Florida | 32720 | — |
| Not listed | Hollywood | Florida | 33021 | — |
| Not listed | Jacksonville | Florida | 32216 | — |
| Not listed | Pensacola | Florida | 32501 | — |
| Not listed | Pinellas Park | Florida | 33781 | — |
| Not listed | Decatur | Georgia | 30033 | — |
| Not listed | Boise | Idaho | 83702 | — |
| Not listed | Meridian | Idaho | 83642 | — |
| Not listed | Towson | Maryland | 21204 | — |
| Not listed | Missoula | Montana | 59802 | — |
| Not listed | Teaneck | New Jersey | 07666 | — |
| Not listed | Greensboro | North Carolina | 27401 | — |
| Not listed | Cincinnati | Ohio | 45242 | — |
| Not listed | Oklahoma City | Oklahoma | 73162 | — |
| Not listed | Johnstown | Pennsylvania | 15901 | — |
| Not listed | State College | Pennsylvania | 16801 | — |
| Not listed | Charleston | South Carolina | 29414 | — |
| Not listed | Dallas | Texas | 75231 | — |
| Not listed | Grapevine | Texas | 76051 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | Lubbock | Texas | 79410 | — |
| Not listed | Plano | Texas | 75093 | — |
| Not listed | San Antonio | Texas | 78205 | — |
| Not listed | San Antonio | Texas | 78233 | — |
| Not listed | Spokane | Washington | 99218 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 84 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00362232, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 3, 2014 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00362232 live on ClinicalTrials.gov.